Earnings History Data for Cytokinetics, Incorporated (CYTK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Cytokinetics, Incorporated

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility. Cytokinetics' lead drug candidate is tirasemtiv, a fast skeletal muscle activator, for the potential treatment of ALS. Tirasemtiv has been granted orphan drug designation and fast track status by the FDA and orphan medicinal product designation by the EMA. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 AH CYTK Cytokinetics, Incorporated 7,650 -1.38 -1.03 -1.45 Cytokinetics GAAP EPS of -$1.38 misses by $0.39, revenue of $1.67M misses by $11.59M
[2/27/2024 4:03 PM]		 73.04 -7.95 
(-9.82%)		 77.83 -3.16 
(-3.90%)		 25.98 - 110.25 4,067,088 1,680,000 19,818
02-11-2023 AH CYTK Cytokinetics, Incorporated 3,350 -1.35 -0.72 -1.28 Cytokinetics GAAP EPS of -$1.35 misses by $0.61
[11/2/2023 4:03 PM]		 36.29 1.65 
(4.76%)		 35.20 0.56 
(1.62%)		 25.98 - 47.49 1,724,027 1,760,000 2,899
03-08-2023 AH CYTK Cytokinetics, Incorporated 3,110 -1.34 -1.23 -0.23 Cytokinetics GAAP EPS of -$1.34 misses by $0.18, revenue of $0.87M misses by $5.18M
[8/3/2023 4:40 PM]		 33.13 1.43 
(4.50%)		 31.70 0.0 
(0.00%)		 30.66 - 55.80 977,474 870,000 8,024
04-05-2023 AH 4:00 PM ET
(May 4)		 CYTK Cytokinetics, Incorporated 3,570 -1.38 -1.24 -1.02 Cytokinetics GAAP EPS of -$1.38 misses by $0.17, revenue of $4.61M beats by $2.11M
[5/4/2023 4:03 PM]		 39.32 0.03 
(0.08%)		 39.29 0.0 
(0.00%)		 32.96 - 55.80 1,562,084 970,000 127,996
01-03-2023 AH 4:00 PM ET
(Mar 1)		 CYTK Cytokinetics, Incorporated 3,950 -1.45 -1.22 -0.36 Cytokinetics GAAP EPS of -$1.45 misses by $0.24, revenue of $1.96M misses by $4.5M
[3/1/2023 4:00 PM]		 39.82 -3.29 
(-7.63%)		 41.17 -1.94 
(-4.50%)		 33.10 - 55.80 1,382,413 900,000 125,053
03-11-2022 AH 4:00 PM ET
(Nov 3)		 CYTK Cytokinetics, Incorporated 4,050 -1.28 -1.19 -0.95 Cytokinetics GAAP EPS of -$1.52 misses by $0.35, revenue of $2.5M misses by $0.73M
[11/3/2022 4:44 PM]		 37.74 -2.01 
(-5.06%)		 39.75 0.0 
(0.00%)		 29.26 - 55.80 1,549,180 1,310,000 25,011
04-08-2022 AH 4:00 PM ET
(Aug 4)		 CYTK Cytokinetics, Incorporated 3,320 -0.23 -1.04 -0.86 Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M
[8/4/2022 4:13 PM]		 51.82 5.10 
(10.92%)		 51.82 0.0 
(0.00%)		 28.66 - 52.69 3,129,904 1,300,000 10,493
04-05-2022 AH 4:00 PM ET
(May 4)		 CYTK Cytokinetics 3,409 -1.02 -0.93 0.00 Cytokinetics GAAP EPS of -$1.05 misses by $0.10, revenue of $1.15M misses by $3.57M
[5/4/2022 4:02 PM]		 40.08 -0.94 
(-2.30%)		 41.03 0.0 
(0.00%)		 17.72 - 47.90 921,562 990,977 18,095
24-02-2022 AH 4:00 PM ET
(Feb 24)		 CYTK Cytokinetics, Incorporated 2,840 -0.36 -0.89 -0.62 Cytokinetics GAAP EPS of -$0.36 beats by $0.51, revenue of $55.6M beats by $50.04M; initiates FY22 guidance
[2/24/2022 4:30 PM]		 34.66 0.72 
(2.11%)		 33.55 -0.40 
(-1.18%)		 17.72 - 47.90 441,120 1,350,000 645
03-11-2021 AH 4:00 PM ET
(Nov 3)		 CYTK Cytokinetics, Incorporated 2,870 -0.95 -0.75 -0.05 Cytokinetics EPS misses by $0.19, misses on revenue
[11/3/2021 4:03 PM]		 39.00 2.33 
(6.35%)		 36.67 0.0 
(0.00%)		 15.17 - 39.75 1,163,381 700,000 7,586
05-08-2021 AH 4:00 PM ET
(Aug 5)		 CYTK Cytokinetics, Incorporated 2,400 -0.86 -0.65 -0.68 Cytokinetics EPS misses by $0.20, misses on revenue
[8/5/2021 4:12 PM]		 31.93 1.69 
(5.59%)		 29.00 -1.24 
(-4.10%)		 14.71 - 32.49 904,122 1,490,000 31,526
06-05-2021 AH 4:00 PM ET
(May 6)		 CYTK Cytokinetics, Incorporated 1,730 -0.66 -0.59 -0.66 Cytokinetics EPS misses by $0.06, misses on revenue
[5/6/2021 4:02 PM]		 24.23 0.86 
(3.68%)		 23.37 0.0 
(0.00%)		 14.71 - 30.14 852,232 840,000 36,963
25-02-2021 AH 4:00 PM ET
(Feb 25)		 CYTK Cytokinetics, Incorporated 1,430 -0.62 -0.48 -0.52 Cytokinetics EPS misses by $0.13, misses on revenue
[2/25/2021 4:19 PM]		 18.86 -0.99 
(-4.99%)		 19.85 0.0 
(0.00%)		 8.00 - 30.14 3,332,057 699,307 11,945
04-11-2020 AH 4:00 PM ET
(Nov 4)		 CYTK Cytokinetics, Incorporated 1,120 -0.05 -0.59 -0.50 Cytokinetics EPS beats by $0.51, beats on revenue
[11/4/2020 4:02 PM]		 17.50 -0.50 
(-2.78%)		 18.00 0.0 
(0.00%)		 7.72 - 30.14 1,317,953 879,129 1,839
06-08-2020 AH 4:00 PM ET
(Aug 6)		 CYTK Cytokinetics, Incorporated 1,600 -0.68 -0.57 -0.56 Cytokinetics EPS misses by $0.09, misses on revenue
[8/6/2020 4:01 PM]		 21.66 0.02 
(0.09%)		 21.75 0.11 
(0.51%)		 7.72 - 29.20 465,345 803,196 222
06-05-2020 AH CYTK Cytokinetics, Incorporated 901.99 -0.66 -0.50 -0.54 0.0 0.0 
(0.00%)		 0.0 0.0 
(0.00%)		 0.0 - 0.0 0 0 0